These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6960081)

  • 21. Econometric analysis of phase duration for blood morphology and basophil count alterations in chronic granulocytic leukaemia.
    Gola A; Smakowska E; Waszkiewicz L; Błaczkowska A; Kin-Dittmann I; Zielińska K; Czajkowska B; Pajsert E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):271-5. PubMed ID: 6205949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic myeloid leukaemia in Malaysian children.
    Sinniah D; Ariffin WA; Shiong HW; Lin HP
    Singapore Med J; 1981 Dec; 22(6):350-3. PubMed ID: 6950522
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adrenal function in chronic myeloid leukemia].
    Podolak-Dawidziak M; Silber-Kasprzak D
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):303-9. PubMed ID: 1069455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of 100 cases of chronic myeloid leukemia with Myleran.
    Pawelski S; Topolska P; Rechowicz K; Krzyzanowska-Wozniakowska
    Pol Med Sci Hist Bull; 1968 Jul; 11(3):101-4. PubMed ID: 5243952
    [No Abstract]   [Full Text] [Related]  

  • 25. The long-term results and survival in the treatment of chronic granulocytic leukaemia with Myleran.
    Chrobák L; Radochová D; Chrobáková H
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969; 12(5):565-70. PubMed ID: 5267593
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of chronic myeloid leukemia: a five-year survey with a comparison of oral busulfan and splenic irradiation.
    Gollerkeri MP; Shah GB
    Cancer; 1971 Mar; 27(3):596-601. PubMed ID: 5279330
    [No Abstract]   [Full Text] [Related]  

  • 27. [Remarks on the course and prognostic factors in a series of chronic myeloid leukemia].
    Furno F; Neretto G; Mazza A; Giovanelli E; Agricola R; Martinetto P
    Arch Sci Med (Torino); 1980; 137(3):499-506. PubMed ID: 6940518
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recent concepts of chronic myeloid leukemia and its treatment].
    Bousser J; Bilski-Pasquier G; Zittoun
    Bull Mem Soc Med Hop Paris; 1966 May 6-20; 117(8):665-74. PubMed ID: 5224894
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytogenetic anomalies in a child born to a mother receiving busulfan for chronic myeloid leukaemia.
    Bhisey AN; Advani SH; Khare AG
    Indian J Cancer; 1982; 19(5):272-6. PubMed ID: 6219940
    [No Abstract]   [Full Text] [Related]  

  • 30. BCG immunotherapy in chronic myelocytic leukaemia.
    Kardaszewicz E; Siejeńska L
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):32-5. PubMed ID: 1063221
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic granulocytic leukaemia. Comparison of uracil mustard and busulphan.
    Herrmann RP; Dougan L; Holt JA; Jackson JM; Matthews ML; Nelson AJ; Stenhouse NS; Woodliff HJ
    Med J Aust; 1972 Apr; 1(16):789-91. PubMed ID: 4503393
    [No Abstract]   [Full Text] [Related]  

  • 32. Splenic irradiation in chronic myeloid leukemia.
    Hukku S; Baboo HA; Venkataratnam S; Vidyasagar MS; Patel NL
    Acta Radiol Oncol; 1983; 22(1):9-12. PubMed ID: 6305140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antimetabolites and pregnancy. Normal child born to a mother under treatment 8 years for chronic myeloid leukemia].
    Salmon M; Orsini A; Giraud F; Perrimond H; Gonggryp N
    Bull Acad Natl Med; 1972 Feb; 156(4):123-32. PubMed ID: 4629812
    [No Abstract]   [Full Text] [Related]  

  • 34. [Observations on the terminal course of chronic myeloid leukemia treated by alkylating agents (busulfan)].
    Giovanelli E
    Minerva Med; 1970 May; 61(37):2038-41. PubMed ID: 4097050
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chronic myeloid leukaemia. Clinical study and analysis of therapeutical results in 55 cases].
    Lamas S; Sanjuán I; Zabala P; Millán I; Cabrera R; Barbolla L; Menéndez J; Fernández MN
    Sangre (Barc); 1982; 27(4A):493-507. PubMed ID: 6961564
    [No Abstract]   [Full Text] [Related]  

  • 36. [Radiation therapy in chronic myeloleukemia].
    Frinovskaia IV; Markarian VG
    Sov Med; 1979 Aug; (8):27-31. PubMed ID: 293054
    [No Abstract]   [Full Text] [Related]  

  • 37. [Analysis of clinical and laboratory prognostic indices in chronic myeloid leukemia (author's transl)].
    Kotlarek-Haus S; Becker M; Dorczak K
    Przegl Lek; 1977; 34(4):407-11. PubMed ID: 267958
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of treatment and survival time in chronic granulocytic leukemia].
    Pawlowski J
    Przegl Lek; 1969; 25(3):305-9. PubMed ID: 4182966
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic myeloid leukaemia: course, life expectancy, and an analysis of dibromomannitol and busulfan treatment.
    Gerhartz H
    Haematologica; 1972 Apr; 57(11):775-86. PubMed ID: 4200312
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of spleen irradiation in 175 clinical cases of chronic myeloid leukemia].
    Schoen D; Bauer R
    Strahlentherapie; 1968 Jan; 135(1):1-10. PubMed ID: 5243751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.